| Literature DB >> 20630765 |
Stefania Ferro1, Laura De Luca, Maria Letizia Barreca, Sara De Grazia, Frauke Christ, Zeger Debyser, Alba Chimirri.
Abstract
The life cycle of HIV-1 requires extensive assistance from the integrase (IN) enzyme which therefore constitutes an attractive therapeutic target for the development of anti-AIDS agents. We herein report the synthesis and biological evaluation of new HIV integrase strand-transfer inhibitors (INSTIs) which proved to be also potent anti-HIV agents. The binding mode of the most representative molecules were also studied by induced-fit docking (IFD). The obtained IFD results were consistent with the mechanism of action proposed for this class of IN inhibitors, that is metal chelating/binding agents. Crown Copyright (c) 2010. Published by Elsevier Ltd. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20630765 DOI: 10.1016/j.bmc.2010.06.063
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641